06
Feb
2008
06
Feb
2008
05
Feb
2008
05
Feb
2008
05
Feb
2008
Posted in I - Series B, Q - 1Q08, R - NORTH EAST, X - Device (Diagnostic)
Primera Biosystems (Mansfield, MA) developer of novel assays and instrument systems to enable simultaneous quantitative measurement of multiples genes in a single assay closed a $21M Series B financing. Participants include Abingworth, Interwest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Company and the Invus Group.
05
Feb
2008
05
Feb
2008
Posted in I - Series B, Q - 1Q08, R - NORTH EAST, X - Renal
Pervasis Therapeutics (Cambridge, MA) is working to regulate vascular repair and restore natural blood flow to critical organs in end-stage renal disease closed a $9.75M Series B financing. Participants include Flagship Venture Partners, Polaris Venture Partners, Highland Capital Partners, and Musket Research Associates.
05
Feb
2008
05
Feb
2008
02
Apr
2007
Posted in I - Series B, Q - 2Q07, R - INTERNATIONAL, X - Inflammation
Nitec Pharma (Switzerland) a drug company focused on the treatment of chronic inflammatory diseases with lead indications in Rheumatoid Arthritis and Polymylagia Rheumatica, raised $26M Series B round. The deal was led by NGN Capital other participants included Atlas Venture and Global Life Science Ventures.